PEGYLATED RECOMBINANT CONSENSUS INTERFERON VERSION CONJUGATE AND PREPARATION METHOD AND USE THEREOF Russian patent published in 2016 - IPC C07K14/555 C07K17/08 C07K1/04 A61K38/21 A61K47/48 A61P31/12 

Abstract RU 2575796 C9

FIELD: chemistry.

SUBSTANCE: invention relates to biotechnology, specifically to obtaining a pegylated recombinant consensus interferon version conjugate, and can be used in medicine. The invention enables to obtain an interferon-based anti-HBV drug, in which the activated PEG molecule is linked through a short linker to the α-amino group of glycine at the N-end of the recombinant consensus interferon version.

EFFECT: invention enables to obtain an anti-HBV drug with high water solubility and low toxicity and immunogenicity compared to a natural interferon.

3 cl, 6 dwg, 12 ex

Similar patents RU2575796C9

Title Year Author Number
PEG-MODIFIED HUMAN INTERFERON β-1a MOLECULE WITH ANTIVIRAL, IMMUNOMODULATORY AND ANTIPROLIFERATIVE ACTIVITY, WITH IMPROVED STABILITY, REDUCED IMMUNOGENICITY, IMPROVED PHARMACOKINETIC AND PHARMACODYNAMIC PARAMETERS, SUITABLE FOR MEDICAL USE, AND IMMUNOBIOLOGICAL FORMULATION BASED THEREON 2013
  • Chernovskaja Tat'Jana Veniaminovna
  • Efanov Jurij Georgievich
  • Morozov Dmitrij Valentinovich
  • Rudenko Elena Georgievna
  • Korzhavin Dmitrij Valer'Evich
  • Ustjugov Jakov Jur'Evich
  • Ivanov Roman Alekseevich
RU2576372C2
NOVEL FUNCTIONALLY ACTIVE, HIGHLY PURE, STABLE CONJUGATE OF INTERFERON α WITH POLYETHYLENE GLYCOL, REPRESENTED BY ONE PEG- NH-IFN POSITIONAL ISOMER, WITH IMPROVED IMMUNOGENICITY, WITH PROLONGED BIOLOGICAL ACTION, SUITABLE FOR MEDICAL APPLICATION, AND IMMUNOLOGICAL AGENT BASED THEREON 2010
  • Chernovskaja Tat'Jana Veniaminovna
  • Denisov Lev Aleksandrovich
  • Morozov Dmitrij Valentinovich
  • Rudenko Elena Georgievna
  • Klenova Angelina Vsevolodovna
RU2447083C1
INTERFERON CONJUGATES AND METHOD FOR PRODUCTION THEREOF 2011
  • Nekrasov Arkadij Vasil'Evich
  • Skrypin Vasilij Ivanovich
  • Puchkova Natal'Ja Grigor'Evna
  • Medvedev Sergej Alekseevich
RU2466138C1
POLYETHYLENE GLYCOL MODIFIED INTERFERON ALPHA 2B, PRODUCING AND USING PREPARATION 2007
  • Tskhou Vajdong
  • Ksiao Kvingdzhiang
  • Sun Li
  • Vang Tibing
  • Jin Fengkhong
  • Luo Shikhong
  • Shuang Lu
  • Liu Min
  • Ksu Tianle
  • Shang Jong
RU2485134C2
PREVENTIVE OR THERAPEUTIC AGENT AGAINST VIRAL DISEASE 2007
  • Khiasa Joiti
  • Kuzukhara Khirojuki
RU2433827C2
LIQUID COMPOSITION OF LONG-ACTING ALPHA INTERFERON CONJUGATE 2011
  • Im Dae Seong
  • Li Dzae Min
  • Li Dzong Soo
  • Bae Sung Min
  • Kvon Se Chang
RU2613905C2
SINGLE NUCLEOTIDE POLYMORPHISM ON CHROMOSOME 15 ENABLING PREDICTION OF HCV TREATMENT RESPONSES 2012
  • Benejd Rima
  • Essyu Loran
  • Navarro Mersidita T.
  • Palermo Dzhuzeppe
  • Rili-Gillis Bridzhit
  • Chzhu Yunkhun
RU2606759C2
COMPLEX FOR ENHANCING IMMUNE RESPONSE 2019
  • Lin, Haixiang
  • Liu, Fang
  • Zha, Li
RU2779622C2
PROTEIN SHOWING INTERFERON-LIKE ANTIVIRAL AND ANTIPROLIFERATIVE BIOLOGICAL ACTIVITIES (VERSIONS), PROTEIN STRUCTURE, CODING POLYNUCLEOTIDE (VERSIONS), EXPRESSION VECTOR, HOST CELL, COMPOSITION AND USE OF PROTEIN AS ANTIVIRAL, ANTIPROLIFERATIVE, ANTICANCER OR IMMUNOMODULATORY AGENT AND METHOD OF TREATING CONDITION SENSITIVE TO INTERFERON-THERAPY, CANCER OR VIRAL DISEASE 2007
  • Van Khajtao
  • Mao Chunshen
  • Li Tszichzhi
  • Van Lin
  • Du Jun
  • Lju Lunbin'
  • Sjuj Tszin
  • Chzhan Zhuj
RU2469091C2
METHOD OF SYNTHESISING CONJUGATES OF GLYCOSEAMINOGLYCANES (GAG) WITH BIOLOGICALLY ACTIVE MOLECULES, POLYMER CONJUGATES AND THEIR RESPECTIVE APPLICATIONS 2010
  • D'Ehste Matteo
  • Ren'Er Davide
  • Pazut Dzhanfranko
  • Rozato Antonio
RU2530649C2

RU 2 575 796 C9

Authors

Fan Kai

Luo Hua

Zhang Jilan

Li Xiang

Zhang Yi

Dates

2016-02-20Published

2011-03-18Filed